ArticleCureus2025
Unmasking the Great Mimic: An Atypical Presentation of Giant Cell Arteritis With Recurrent and Isolated Diplopia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant cell arteritis (GCA) is a well-recognized vasculitis, typically presenting with headaches, scalp tenderness, jaw claudication, polymyalgia rheumatica, or constitutional symptoms. In stroke and transient ischemic attack (TIA) clinics, GCA is primarily considered in cases of visual loss due to ophthalmic artery involvement. However, diplopia as an isolated manifestation of GCA is exceedingly rare, making early recognition challenging. We present the case of a 75-year-old man who attended our TIA clinic with seven recurrent episodes of transient binocular diplopia. Notably, he lacked the classical features of GCA, including headache, scalp tenderness, jaw claudication, or visual loss. There was no history of fever, night sweats, weight loss, or other systemic symptoms. His neurological examination was unremarkable, and he denied any recent trauma or medication changes. However, routine inflammatory markers revealed a significantly elevated erythrocyte sedimentation rate (ESR) and CRP, raising suspicion for an underlying inflammatory process. An urgent rheumatology assessment and temporal artery ultrasound demonstrated increased intima-media thickness in the superficial temporal, frontal, and axillary arteries, confirming the diagnosis of GCA. He was promptly initiated on high-dose prednisolone (1 mg/kg) with a structured 16.5-month tapering regimen. Following treatment, his diplopia resolved completely, and inflammatory markers normalized. At both three-month and six-month follow-ups, he remained asymptomatic. To our knowledge, this is an extremely rare case of GCA presenting with isolated, recurrent diplopia rather than the typical pattern of visual loss. We propose that the underlying mechanism may involve intracranial vasculitis affecting the posterior circulation, particularly the midbrain and pons, or ischemia of the extraocular muscles due to ophthalmic artery involvement. This case highlights the protean nature of GCA, reinforcing its reputation as the "great mimic." Clinicians should maintain a high index of suspicion for GCA in older patients presenting with transient diplopia, even in the absence of classical symptoms. Routine ESR and CRP testing in TIA clinics could facilitate early diagnosis, preventing irreversible visual or cerebrovascular complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.